CYTK – cytokinetics, incorporated (US:NASDAQ)
Stock Stats
News
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $120.00 price target on the stock.
Edgewise Therapeutics Stock Plummets on Drug Trial 'Adverse Events' [Yahoo! Finance]
Cytokinetics to Participate in the 24th Annual Needham Virtual Healthcare Conference
Cytokinetics (CYTK) Moves 5.4% Higher: Will This Strength Last? [Yahoo! Finance]
Cytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy Community [Yahoo! Finance]
Form 4 CYTOKINETICS INC For: Apr 07 Filed by: Callos Andrew
Form 144 CYTOKINETICS INC Filed by: Callos Andrew
Form 4 CYTOKINETICS INC For: Apr 03 Filed by: Harrington Robert Arthur
Form 4 CYTOKINETICS INC For: Mar 31 Filed by: Blum Robert I
Form PRE 14A CYTOKINETICS INC For: May 14
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.